A phase I study of bi-weekly administration of 24-h gemcitabine followed by 24-h irinotecan in patients with solid tumors

Author： Saif Muhammad   Sellers Sandra   Li Mao   Wang Wei   Cusimano Linda   Wang Hui   Zhang Ruiwen  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.60, Iss.6, 2007-11, pp. : 871-882

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A Phase I Dose-Finding Study Using an Innovative Sequential Biweekly Schedule of Irinotecan Followed 24 Hours Later by Capecitabine

By Hirawat Samit   Kolitz Jonathan   Lichtman Stuart M.   Allen Steven L.   Villani Gina   Gonzales Alma   Fricano Marjorie   Budman Daniel R.  

Cancer Investigation, Vol. 25, Iss. 3, 2007-04 ,pp. : 148-153

Informa Healthcare

Access to resources Recommend Favorite

A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound, administered as a 24-h continuous infusion in patients with advanced solid tumors

By Gordon Michael   Ilaria Robert   Alwis Dinesh   Mendelson David   McKane Scott   Wagner Margaret   Look Katherine   LoRusso Patricia  

Cancer Chemotherapy and Pharmacology, Vol. 71, Iss. 1, 2013-01 ,pp. : 21-27

Springer Publishing Company

Access to resources Recommend Favorite

A phase I–II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane + platinum-based regimens

By Kosmas Christos   Tsavaris Nicolas   Syrigos Konstantinos   Koutras Angelos   Tsakonas George   Makatsoris Thomas   Mylonakis Nicolas   Karabelis Athanasios   Stathopoulos George   Kalofonos Haralambos  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 1, 2007-01 ,pp. : 51-59

Springer Publishing Company

Access to resources Recommend Favorite

Phase I study of irinotecan by 24-h intravenous infusion in combination with 5-fluorouracil in metastatic colorectal cancer

By Kambe Mariko   Kikuchi Hiroaki   Gamo Makio   Yoshioka Takashi   Ohashi Yasuo   Kanamaru Ryunosuke  

International Journal of Clinical Oncology, Vol. 17, Iss. 2, 2012-04 ,pp. : 150-154

Springer Publishing Company

Access to resources Recommend Favorite

A weekly 24-h infusion of high-dose 5-fluorouracil (5-FU)+leucovorin and bi-weekly cisplatin (CDDP) was active and well tolerated in patients with non-colon digestive carcinomas

By Caroli-Bosc F.X.   Van Laethem J.L.   Michel P.   Gay F.   Hendlisz A.   Forget F.   Bleiberg H.  

European Journal of Cancer, Vol. 37, Iss. 15, 2001-10 ,pp. : 1828-1832

Elsevier

Access to resources Recommend Favorite